Device Recall VITROS Chemistry Products Specialty Diluent 의 리콜

Recall

67883

Class 2

Z-1519-2014

2014-03-26

2014-04-28

Terminated

United States

2017-03-27

USFDA

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=126555

Ortho clinical diagnostics (ocd) confirmed the potential for lower than expected c-reactive protein (crp) results only to be generated when using vitros chemistry products specialty diluent (lot f3168) or vitros chemistry products fs diluent pack 3 (lot 01-3266). the vitros instructions for use states that if the if a c-reactive protein concentration exceeds the systems measuring (reportable or dynamic) range, dilute the sample with vitros specialty diluent or a patient sample containing a low concentration of crp. an initial threefold dilution is recommended. internal testing determined that results using vitros crp slides have the potential for approximately 51% bias using a 3x dilution factor.

On 3/26/2014, Urgent Product Correction Notification Letters were sent via FedEx overnight courier and/or US Postal Service Priority Mail (for PO Boxes only) to US consignees (OCD Direct, Drop-Ship and US Federal Government) to inform them of the issue and advise them to discontinue use of the affected lot(s), discard the affected lots and to inform their Laboratory Medical Director if they suspect that a previously reported result may have been affected. Replacement product will be sent for the product discarded. J&J; Foreign affiliate consignees were notified by e-mail informing them of the issue on 3/26/2014.